Neyssa Marina

Clinical Focus

• Hematology/Oncology/Stem Cell Transplant, Pediatric
• Oncology (Cancer), Pediatric
• Pediatric Hematology-Oncology

Administrative Appointments

• Director, Pediatric Hematology-Oncology Fellowship Program, Stanford University (2000 - present)
• Director of Hematology-Oncology Outpatient Clinic, Lucile Packard Children's Hospital (2000 - present)
• Associate Chief of Clinical Affairs, Pediatric Hematology-Oncology, Lucile Packard Children's Hospital (2006 - present)

Honors and Awards

• Alfa Omega Alfa Honor Society, Alfa Omega Alfa (1982)
• Phi Kappa Phi Honor Society, Phi Kappa Phi (1979)
• Magna Cum Laude-Antoine Lavoiser Chemistry Award, University of PR, Mayaguez Campus (1979)

Professional Education

Postdoctoral Advisees

Jay Balagtas, Jin Chang, Kristin Edgehouse, Clara Lo, John Tan, Michael Wei

Graduate & Fellowship Program Affiliations

• Pediatrics

Research Interests

The main focus of my research is the development of new treatment strategies for patients with bone sarcoma.

Clinical Trials

• Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor Recruiting
• A Children’s Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens Recruiting
• A Study of Pemetrexed in Children With Recurrent Cancer Recruiting
• AEWS07B1: A COG Study for Collecting and Banking Ewing Sarcoma Specimens Recruiting
• Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Recruiting

Publications

• Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour. Daw NC, Gregornik D, Rodman J, Marina N, Wu J, Kun LE, Jenkins JJ, McPherson V, Wilimas J, Jones DP. Eur J Cancer. 2009; 45 (1): 99-106
• Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group. DuBois SG, Krailo MD, Lessnick SL, Smith R, Chen Z, Marina N, Grier HE, Stegmaier K. Pediatr Blood Cancer. 2009; 52 (3): 324-7
• Immune approaches to treating osteosarcoma. Marina N, Gorlick R. Cancer Biol Ther. 2009; 8 (10): 981-3
• Physical performance limitations in the Childhood Cancer Survivor Study cohort. Ness KK, Hudson MM, Ginsberg JP, Nagarajan R, Kaste SC, Marina N, Whitton J, Robison LL, Gurney JG. J Clin Oncol. 2009; 27 (14): 2382-9
• The role of interferons in the treatment of osteosarcoma. Whelan J, Patterson D, Perisoglou M, Bielack S, Marina N, Smeland S, Bernstein M. Pediatr Blood Cancer. 2009